Kolexia
Boyer Olivia
Pédiatrie
Hôpital Necker Enfants Malades
Paris, France
260 Activités
39 Followers

Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} Syndrome néphrotique Maladies du rein Défaillance rénale chronique Syndrome hémolytique et urémique Insuffisance rénale Syndrome hémolytique et urémique atypique Protéinurie Glomérulonéphrite Acidose tubulaire rénale

Industries

Biocodex
4 collaboration(s)
Dernière en 2022
Takeda Pharmaceutical
2 collaboration(s)
Dernière en 2020
Alexion
2 collaboration(s)
Dernière en 2022
retrophin
2 collaboration(s)
Dernière en 2021

Dernières activités

CYSTEA-BONE: A European, Multicenter, Prospective Clinical Study to Evaluate Cysteamine Toxicity on Human Osteoclasts. The CYSTEA-BONE Clinical Study.
Essai Clinique (Hospices Civils de Lyon)   27 février 2024
Performance and clinical utility of a new supervised machine-learning pipeline in detecting rare ciliopathy patients based on deep phenotyping from electronic health records and semantic similarity.
Orphanet journal of rare diseases   10 février 2024
TOTEM: Therapeutic Orientation Test in Thrombotic Microangiopathy
Essai Clinique (CHU Montpellier)   25 janvier 2024
DAILY-LUMA: Retrospective and Prospective Follow-up of Patients With Primary Hyperoxaluria Type 1 Treated With Lumasiran in France - DAILY-LUMA
Essai Clinique (Hospices Civils de Lyon)   17 janvier 2024
Steroid-Resistant Nephrotic Syndrome due to NPHS2 Variants Is Not Associated With Posttransplant Recurrence
Kidney international reports   10 janvier 2024
Corrigendum to "A multicenter retrospective study of calcineurin inhibitors in nephrotic syndrome secondary to podocyte gene variants." Kidney Int. 2023;103:962-972.
Kidney international   05 janvier 2024
A Study to Evaluate the Benefits and Risks of Conversion of Existing Adolescent Kidney Transplant Recipients Aged 12 to <18 Years to a Belatacept-based Immunosuppressive Regimen as Compared to Continuation of a Calcineurin Inhibitor-based Regimen, and Their Adherence to Immunosuppressive Medications: A Prospective, Open-label, Multicenter, Randomized Study to Evaluate the Benefits and Risks of Conversion of Existing Adolescent Renal Allograft Recipients Aged 12 to Less Than 18 Years of Age to a Belatacept-based Immunosuppressive Regimen as Compared to Continuation of a Calcineurin Inhibitor-based Regimen, and Their Adherence to Immunosuppressive Medications
Essai Clinique (BMS)   04 janvier 2024
Interview avec Pr Olivia Boyer : un résumé de ses ... - Facebook
Facebook   03 novembre 2023
Voice of a caregiver: call for action for multidisciplinary teams in the care for children with atypical hemolytic uremic syndrome.
Pediatric nephrology (Berlin, Germany)   02 octobre 2023
Is ABO Incompatible Living Donor Kidney Transplantation in Children a Better Option than the Use of Optimal Grafts From Deceased Donors? A Plea for Better Prioritization of Deceased Kidney Grafts for Children.
Transplant international : official journal of the European Society for Organ Transplantation   18 septembre 2023